Chemoprevention in familial adenomatous polyposis - PubMed (original) (raw)

Review

Chemoprevention in familial adenomatous polyposis

Brian Kim et al. Best Pract Res Clin Gastroenterol. 2011 Aug.

Abstract

Familial adenomatous polyposis (FAP) predictably leads to adenomas and eventual adenocarcinomas in the lower gastrointestinal tract and less frequently, the upper gastrointestinal tract. Chemopreventive strategies have been studied in FAP patients to delay the development of adenomas in the upper and lower gastrointestinal tract, as well as to prevent recurrence of adenomas in the retained rectum of patients after prophylactic surgery with colectomy and ileorectal anastamosis (IRA). The nonsteroidal anti-inflammatory drug (NSAID) sulindac and selective cyclooxygenase-2 (COX-2) inhibitor celecoxib reduce polyposis of the retained rectum after colectomy with IRA. Reports of cardiovascular risks of some NSAIDs and selective COX-2 inhibitors have led to promising studies of lower doses in combination with ursodeoxycholic acid, statin, and difluoromethylornithine. Curcumin and eicosapentaenoic acid show efficacy in small clinical trials of FAP chemoprevention. This article will review the concept of chemoprevention and the current clinical literature in FAP chemoprevention.

Copyright © 2011 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Figures

Fig. 1

Mechanisms of chemoprevention.

Similar articles

• Chemoprevention with special reference to inherited colorectal cancer.
  Lynch PM. Lynch PM. Fam Cancer. 2008;7(1):59-64. doi: 10.1007/s10689-007-9158-4. Epub 2007 Aug 7. Fam Cancer. 2008. PMID: 17680350
• Chemoprevention of colorectal cancer: systematic review and economic evaluation.
  Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P. Cooper K, et al. Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Health Technol Assess. 2010. PMID: 20594533 Review.
• Regression of Colonic Adenomas After Treatment With Sulindac in Familial Adenomatous Polyposis: A Case With a 2-Year Follow-up Without a Prophylactic Colectomy.
  Kim KY, Jeon SW, Park JG, Yu CH, Jang SY, Lee JK, Hwang HY. Kim KY, et al. Ann Coloproctol. 2014 Aug;30(4):201-4. doi: 10.3393/ac.2014.30.4.201. Epub 2014 Aug 26. Ann Coloproctol. 2014. PMID: 25210691 Free PMC article.
• Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome.
  Stone JK, Mehta NA, Singh H, El-Matary W, Bernstein CN. Stone JK, et al. Fam Cancer. 2023 Oct;22(4):413-422. doi: 10.1007/s10689-023-00334-3. Epub 2023 Apr 29. Fam Cancer. 2023. PMID: 37119510 Review.

Cited by

• Cholinergic Mechanisms in Gastrointestinal Neoplasia.
  Sampaio Moura N, Schledwitz A, Alizadeh M, Kodan A, Njei LP, Raufman JP. Sampaio Moura N, et al. Int J Mol Sci. 2024 May 13;25(10):5316. doi: 10.3390/ijms25105316. Int J Mol Sci. 2024. PMID: 38791353 Free PMC article. Review.
• Surgical Decision-Making in Familial Adenomatous Polyposis.
  Steinberger AE, Westfal ML, Wise PE. Steinberger AE, et al. Clin Colon Rectal Surg. 2023 Aug 10;37(3):191-197. doi: 10.1055/s-0043-1770732. eCollection 2024 May. Clin Colon Rectal Surg. 2023. PMID: 38617844 Free PMC article. Review.
• Evaluation of EGFR and COX pathway inhibition in human colon organoids of serrated polyposis and other hereditary cancer syndromes.
  Kanth P, Hazel MW, Schell JC, Rutter J, Yao R, Mills AP, Delker DA. Kanth P, et al. Fam Cancer. 2024 Nov;23(4):479-489. doi: 10.1007/s10689-024-00370-7. Epub 2024 Apr 12. Fam Cancer. 2024. PMID: 38609520 Free PMC article.
• Eflornithine for chemoprevention in the high-risk population of colorectal cancer: a systematic review and meta-analysis with trial sequential analysis.
  Yang L, Wang Y, Hu S, Wang X. Yang L, et al. Front Oncol. 2023 Nov 15;13:1281844. doi: 10.3389/fonc.2023.1281844. eCollection 2023. Front Oncol. 2023. PMID: 38033490 Free PMC article.
• Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients.
  Lanas A, Tacconelli S, Contursi A, Piazuelo E, Bruno A, Ronci M, Marcone S, Dovizio M, Sopeña F, Falcone L, Milillo C, Mucci M, Ballerini P, Patrignani P. Lanas A, et al. Cancers (Basel). 2023 Apr 25;15(9):2457. doi: 10.3390/cancers15092457. Cancers (Basel). 2023. PMID: 37173923 Free PMC article.

References

1. 1. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253:661–5. - PubMed
2. 1. Vasen HFA, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP) Gut. 2008;57:704–13. - PubMed
3. 1. Aziz O, Athanasiou T, Fazio VW, Nicholls RJ, Darzi AW, Church J, et al. Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg. 2006;93:407–17. - PubMed
4. 1. Heiskanen I, Jarvinen HJ. Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Int J Colorectal Dis. 1997;12:9–13. - PubMed
5. 1. Bulow S, Bjork J, Christensen IJ, Fausa O, Jarvinen H, Moesgaard F, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut. 2004;53:381–6. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal